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Background
A4001078 is a study in therapy naive patients of Mara-
viroc (MVC) plus boosted atazanavir. The Trofile ES
(ESTA) was used to determine tropism at Screening.
Few re-analyses of genotypic tropism have examined all
screened and non-reportable (NR) populations. We
aimed to define correlations between methods at screen-
ing and evaluate the quantity of X4 using virus in dis-
cordant results using ultra-deep sequencing (UDS).
Methods
Population and UDS methods were employed on 178 of
220 screened subjects and 121 enrolled subjects. Corre-
lation between methods was explored and the quantity
of X4-using virus in both discordant and concordant
samples was measured using UDS.
Results
ESTA defined 123 (69%) as R5, 39 (22%) as Dual or
Mixed tropism (D/M) and 16 (9%) as NR. Population
sequencing (single amplification) defined 146 (82%) as
R5, 26 as X4, and 6 tests were non reportable [Either
failure to get a PCR product (no result for both, popu-
lation sequencing and UDS) or non-evaluable Sanger
traces]. Correlation between population and UDS for
R5 use was 95%. Of the patients screened as R5 by
population sequencing, UDS showed a median of 0%
X4 with only 3 of 114 results being over 2% X4 use,
suggesting this method is suitable for selecting indivi-
duals for CCR5 antagonist therapy. All Trofile NR
r e s u l t sw e r er e p o r t a b l eb yp o p u l a t i o ns e q u e n c i n ga n d
showed tropism results consistent with the overall
population.
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Figure 1 Correlation between methods and quantity of X4 use by UDS in concordant and discordant results and quantity of X4 using virus by
UDS.
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Population sequencing appropriately identified patients
with <2% CXCR4 using virus and who would be suitable
for CCR5 antagonist therapy.
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